{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:43:20Z","timestamp":1790790200039,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":664,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The prevalence of transthyretin-associated amyloidosis cardiomyopathy (ATTR-CM) has grown because of newer non-invasive diagnosis tools. Detecting the presence of extra-cardiac ATTR manifestations such as musculoskeletal pathologies considered \u2018red flags\u2019, when there is minimal or non-cardiac clinical involvement is primordial to carry out an early diagnosis. The aim of this systematic review is to examine the prevalence of musculoskeletal, ATTR-deposition-related co-morbidities in patients already diagnosed with ATTR-CM, specifically carpal tunnel syndrome, ruptured biceps tendon, spinal stenosis, and trigger finger. We performed a systematic review using PRISMA guidelines. Inclusion criteria were all studies in English and Spanish language and participants had to be patients diagnosed with ATTR-CM, by any diagnostic method, with the musculoskeletal co-morbidities subject of this review. The quality of the studies was based on the Risk of Bias Tool. This systematic review included 22 studies for final analysis. Carpal tunnel syndrome is reported in 21 studies, brachial biceps tendon rupture is reported in three, and spinal stenosis in eight studies. No articles that accomplished all the inclusion criteria for trigger finger were found. Regarding to the quality of the studies, all of them were categorized as being of high and moderate quality. The frequent association between ATTR-CM and carpal tunnel syndrome, ruptured biceps tendon, and lumbar spinal is confirmed, and the onset of these co-morbidities usually precedes the diagnosis of by years. This association defines them as red flags that should be search proactively due to the current treatment possibilities and the severity of the presentation of cardiac amyloidosis.<\/jats:p>","DOI":"10.1002\/ehf2.14622","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T01:04:44Z","timestamp":1703207084000},"page":"662-671","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Musculoskeletal Co-Morbidities in Patients with Transthyretin Amyloid Cardiomyopathy: A Systematic Review"],"prefix":"10.1093","volume":"11","author":[{"given":"Francesc","family":"Formiga","sequence":"first","affiliation":[{"name":"Geriatric Unit, Internal Medicine Department, Hospital Universitari de Bellvitge, Systemic Diseases and Ageing Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de LLobregat , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia Saumell","family":"Baeza","sequence":"additional","affiliation":[{"name":"Geriatric Unit, Internal Medicine Department, Hospital Universitari de Bellvitge, Systemic Diseases and Ageing Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de LLobregat , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chivite","sequence":"additional","affiliation":[{"name":"Geriatric Unit, Internal Medicine Department, Hospital Universitari de Bellvitge, Systemic Diseases and Ageing Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de LLobregat , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Yun","sequence":"additional","affiliation":[{"name":"Geriatric Unit, Internal Medicine Department, Hospital Universitari de Bellvitge, Systemic Diseases and Ageing Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de LLobregat , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"2026012113154706300_ehf214622-bib-0001","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"2026012113154706300_ehf214622-bib-0002","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012113154706300_ehf214622-bib-0003","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1161\/CIRCULATIONAHA.116.024438","article-title":"Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis","volume":"135","author":"Maurer","year":"2017","journal-title":"Circulation"},{"key":"2026012113154706300_ehf214622-bib-0004","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012113154706300_ehf214622-bib-0005","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.regg.2020.05.001","article-title":"Amiloidosis por transtiretina: lo que ahora vemos es solo la punta del iceberg","volume":"55","author":"Yun","year":"2020","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"2026012113154706300_ehf214622-bib-0006","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"key":"2026012113154706300_ehf214622-bib-0007","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis","volume":"68","author":"Maurer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026012113154706300_ehf214622-bib-0008","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","article-title":"Cardiac amyloidosis: The great pretender","volume":"20","author":"Rapezzi","year":"2015","journal-title":"Heart Fail Rev"},{"key":"2026012113154706300_ehf214622-bib-0009","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","article-title":"ATTR amyloidosis: current and emerging management strategies: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Griffin","year":"2021","journal-title":"JACC CardioOncol"},{"key":"2026012113154706300_ehf214622-bib-0010","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.recesp.2017.05.018","article-title":"Diagnosis and treatment of transthyretin cardiac amyloidosis. Progress and Hope","volume":"70","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2026012113154706300_ehf214622-bib-0011","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026012113154706300_ehf214622-bib-0012","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: Modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"2026012113154706300_ehf214622-bib-0013","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/13506129.2018.1498782","article-title":"Seven factors predict a delayed diagnosis of cardiac amyloidosis","volume":"25","author":"Bishop","year":"2018","journal-title":"Amyloid"},{"key":"2026012113154706300_ehf214622-bib-0014","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1212\/CPJ.0000000000000640","article-title":"Carpal tunnel syndrome and associated symptoms as first manifestation of hATTR amyloidosis","volume":"9","author":"Karam","year":"2019","journal-title":"Neurol Clin Pract"},{"key":"2026012113154706300_ehf214622-bib-0015","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2017.9236","article-title":"Association between ruptured distal biceps tendon and wild-type transthyretin cardiac amyloidosis","volume":"318","author":"Geller","year":"2017","journal-title":"JAMA"},{"key":"2026012113154706300_ehf214622-bib-0016","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3233\/JND-210656","article-title":"Hereditary transthyretin amyloidosis\u2014Clinical and genetic characteristics of a multiracial south-east Asian cohort in Singapore","volume":"8","author":"Chen","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"2026012113154706300_ehf214622-bib-0017","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3109\/13506129.2015.1135792","article-title":"Carpal tunnel syndrome: A common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis","volume":"23","author":"Nakagawa","year":"2016","journal-title":"Amyloid"},{"key":"2026012113154706300_ehf214622-bib-0018","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jjcc.2022.01.002","article-title":"Incidence, clinical characteristics, and diagnostic approach in transthyretin amyloid cardiomyopathy: The Kumamoto cardiac amyloidosis survey","volume":"80","author":"Takashio","year":"2022","journal-title":"J Cardiol"},{"key":"2026012113154706300_ehf214622-bib-0019","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jjcc.2021.10.007","article-title":"Sex-related differences in the clinical characteristics of wild-type transthyretin amyloidosis cardiomyopathy","volume":"79","author":"Takashio","year":"2022","journal-title":"J Cardiol"},{"key":"2026012113154706300_ehf214622-bib-0020","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.900313","article-title":"Clinical profile and prognosis of hereditary transthyretin amyloid cardiomyopathy: A single-center study in South China","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026012113154706300_ehf214622-bib-0021","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/ehf2.12884","article-title":"Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan","volume":"7","author":"Yamada","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026012113154706300_ehf214622-bib-0022","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.cardfail.2020.06.009","article-title":"Prior carpal tunnel syndrome and early concomitant echocardiographic findings among patients with cardiac amyloidosis","volume":"26","author":"Itzhaki Ben Zadok","year":"2020","journal-title":"J Card Fail"},{"key":"2026012113154706300_ehf214622-bib-0023","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.3390\/jcm9072234","article-title":"Hereditary attr amyloidosis in Austria: Prevalence and epidemiological hot spots","volume":"9","author":"Auer-Grumbach","year":"2020","journal-title":"J Clin Med"},{"key":"2026012113154706300_ehf214622-bib-0024","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00392-019-01467-1","article-title":"Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?","volume":"108","author":"aus dem Siepen","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"2026012113154706300_ehf214622-bib-0025","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.medcli.2021.10.018","article-title":"Cardiac amyloidosis: Description of a series of 143 cases","volume":"159","author":"Barge-Caballero","year":"2022","journal-title":"Med Clin (Barc)"},{"key":"2026012113154706300_ehf214622-bib-0026","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/joim.13200","article-title":"Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype","volume":"289","author":"Cappelli","year":"2021","journal-title":"J Intern Med"},{"key":"2026012113154706300_ehf214622-bib-0027","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/00015385.2021.1976450","article-title":"Trends in diagnosis, referral, red flag onset, patient profiles and natural outcome of de novo cardiac amyloidosis and their multidisciplinary implications","volume":"77","author":"Debonnaire","year":"2022","journal-title":"Acta Cardiol"},{"key":"2026012113154706300_ehf214622-bib-0028","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/ejhf.1285","article-title":"Phenotypic profile of Ile68Leu transthyretin amyloidosis: An underdiagnosed cause of heart failure","volume":"20","author":"Gagliardi","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2026012113154706300_ehf214622-bib-0029","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1093\/eurheartj\/ehw033","article-title":"Aortic stenosis and transthyretin cardiac amyloidosis: The chicken or the egg?","volume":"37","author":"Galat","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012113154706300_ehf214622-bib-0030","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.recesp.2019.12.017","article-title":"Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center","volume":"74","author":"L\u00f3pez-Sainz","year":"2021","journal-title":"Rev Esp Cardiol"},{"key":"2026012113154706300_ehf214622-bib-0031","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/13506129.2021.1976751","article-title":"Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: Impact on patient management and new insights in wild-type","volume":"29","author":"Papagianni","year":"2022","journal-title":"Amyloid"},{"key":"2026012113154706300_ehf214622-bib-0032","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: Disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"2026012113154706300_ehf214622-bib-0033","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jaccao.2021.05.004","article-title":"Two decades of cardiac amyloidosis: A Danish nationwide study","volume":"3","author":"Westin","year":"2021","journal-title":"JACC CardioOncol"},{"key":"2026012113154706300_ehf214622-bib-0034","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ejhf.1742","article-title":"Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies","volume":"22","author":"Milandri","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026012113154706300_ehf214622-bib-0035","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.amjcard.2022.11.014","article-title":"Prevalence of orthopedic manifestations in patients with cardiac amyloidosis with a focus on shoulder pathologies","volume":"190","author":"Basdavanos","year":"2023","journal-title":"Am J Cardiol"},{"key":"2026012113154706300_ehf214622-bib-0036","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1186\/s12891-023-06853-5","article-title":"Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: A systematic review","volume":"24","author":"Aldinc","year":"2023","journal-title":"BMC Musculoskelet Disord"},{"key":"2026012113154706300_ehf214622-bib-0037","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/14737167.2021.1933948","article-title":"Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain","volume":"21","author":"Formiga","year":"2021","journal-title":"Expert Rev Pharmacoecon Outcomes Res"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/2\/662\/64540226\/eschf_11_2_662.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/2\/662\/64540226\/eschf_11_2_662.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:17:48Z","timestamp":1769019468000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/2\/662\/8271336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,12,21]]},"published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14622","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2023,12,21]]},"assertion":[{"value":"2023-09-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}